Quadrant Capital Group LLC Ligand Pharmaceuticals Inc Transaction History

Quadrant Capital Group LLC

  • $1.42 Billion
  • Q3 2024

A detailed history of Quadrant Capital Group LLC transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Quadrant Capital Group LLC holds 37 shares of LGND stock, worth $4,526. This represents 0.0% of its overall portfolio holdings.

Number of Shares
37
Previous 37 -0.0%
Holding current value
$4,526
Previous $3,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 08, 2024
SELL
$49.57 - $72.63 $5,452 - $7,989
-110 Reduced 74.83%
37 $2,000
Q3 2023

Nov 14, 2023
SELL
$58.86 - $72.67 $6,298 - $7,775
-107 Reduced 42.13%
147 $8,000
Q2 2023

Aug 09, 2023
BUY
$69.53 - $79.33 $486 - $555
7 Added 2.83%
254 $18,000
Q1 2023

May 11, 2023
BUY
$65.67 - $77.08 $7,026 - $8,247
107 Added 76.43%
247 $18,000
Q4 2022

Feb 10, 2023
SELL
$61.72 - $96.74 $802 - $1,257
-13 Reduced 8.5%
140 $9,000
Q3 2022

Nov 10, 2022
BUY
$0.01 - $107.56 $1 - $14,735
137 Added 856.25%
153 $13,000
Q2 2022

Aug 09, 2022
BUY
$74.52 - $117.06 $298 - $468
4 Added 33.33%
16 $1,000
Q4 2021

Feb 01, 2022
SELL
$127.69 - $165.85 $766 - $995
-6 Reduced 33.33%
12 $2,000
Q3 2021

Nov 12, 2021
BUY
$102.33 - $144.73 $613 - $868
6 Added 50.0%
18 $3,000
Q4 2020

Feb 16, 2021
BUY
$80.55 - $106.05 $966 - $1,272
12 New
12 $1,000
Q3 2020

Nov 13, 2020
SELL
$89.56 - $126.72 $4,388 - $6,209
-49 Closed
0 $0
Q2 2020

Aug 13, 2020
SELL
$68.28 - $123.65 $36,256 - $65,658
-531 Reduced 91.55%
49 $5,000
Q1 2020

May 15, 2020
BUY
$63.37 - $107.88 $36,120 - $61,491
570 Added 5700.0%
580 $42,000
Q4 2019

Feb 03, 2020
SELL
$96.94 - $113.59 $1,066 - $1,249
-11 Reduced 52.38%
10 $0
Q3 2019

Oct 24, 2019
SELL
$86.25 - $120.16 $25,185 - $35,086
-292 Reduced 93.29%
21 $1,000
Q2 2019

Jul 24, 2019
BUY
$107.38 - $129.34 $31,354 - $37,767
292 Added 1390.48%
313 $34,000
Q1 2019

Apr 29, 2019
SELL
$105.93 - $142.47 $953 - $1,282
-9 Reduced 30.0%
21 $1,000
Q4 2018

Jan 17, 2019
SELL
$128.36 - $272.13 $1,668 - $3,537
-13 Reduced 30.23%
30 $3,000
Q2 2018

Aug 09, 2018
BUY
$150.77 - $207.98 $1,960 - $2,703
13 Added 43.33%
43 $7,000
Q3 2017

Oct 13, 2017
BUY
$120.91 - $137.94 $1,692 - $1,931
14 Added 87.5%
30 $3,000
Q2 2017

Aug 15, 2017
BUY
N/A
16
16 $0

Others Institutions Holding LGND

# of Institutions
257
Shares Held
18.2M
Call Options Held
26.8K
Put Options Held
9.3K
View Full List

About LIGAND PHARMACEUTICALS INC

LGND Quotes by TradingView
  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $2.07B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track Quadrant Capital Group LLC Portfolio

Follow Quadrant Capital Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadrant Capital Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email